Ophthalmic administration of CXCR3 antagonist decreases intraocular pressure in a rat model of ocular hypertension. by Alexandre Denoyer (160189)

“…<p><i>(A)</i> A single administration of CXCR3 antagonist (NBI-74330, 1 µM, 100 µL) induces a transient decrease in intraocular pressure (n = 10 in each group). …”

Exploration of the connected interface (S100A1/p53 (1–73)) section in S100A1. by Deepu Dowarha (5673440)

Subjects:

Decrease in extracellular Zn²⁺ in the hippocampus by zinc chelators. by Atsushi Takeda (18203)

“…<p>Hippocampal slices were prepared 2 h after i.p. injection of vehicle (A, n = 7) or CQ (30 mg/kg, B, n = 5) into NER, and 3 h after i.p. injection of vehicle (C, n = 7) or TPEN (1 mg/kg, D, n = 8) into NER. …”

Capzb2 coimmunoprecipitates with βIII-tubulin in brain lysates and decreases tubulin polymerization in vitro. by David A. Davis (239142)

“…(E) Capzb2 decreases the rate and the extent of tubulin polymerization in a concentration-dependent manner. …”

Demonstration of decreased Aβ accumulation by DA-9601 treatment. by Mijung Lee (397790)

OPN-deficiency decreases inflammation, oxidative stress and fibrosis in adipose tissue. by Andoni Lancha (335824)

TGF-β1 increased the expression of biglycan and decreased the expression of decorin. by Youssef M. Farhat (295089)

Combined EGCG/As decreases the viability of two types of EC, HUVEC and HBMEC. by Jee-Youn Kim (796526)

Effect of lysosomal hydrolysis inhibition on the decrease of PrP^Sc levels induced by CPZ or U18666A treatment. by Takeshi Yamasaki (521196)

Combination of MK-2206 and R5020 significantly decreases cell viability. by Alok Pant (314711)

SETD2 loss of function in BMSCs showed decreased bone mass. by Lijun Wang (176511)

GSK343 decreased viability and proliferation in human neuroblastoma PDX cells. by Laura V. Bownes (10276762)

“…Treatment with GSK343 resulted in significantly decreased migration. (D) After 24 hours of treatment with increasing concentrations of GSK343 (0, 5, 10 μM), COA3 and COA6 cells (4.0 × 10⁴) were plated in Transwell^® inserts and allowed to invade for 1 week through a Matrigel^™ layer. …”

LPS dose-dependently decreases T cell proliferative response to OKT3. by Fanny Poujol (834338)

Chronic RAS blockade decreases AT₁R expression. by Lai Ming Yung (353970)

Overexpression of active Fyn decreases clonogenicity in the absence of BCR-ABL1. by Melissa M. Singh (293682)

Treatment with HBOT or PFD decreased the frequency of mast cells in the AD lesions. by Hyung-Ran Kim (532404)

Treatment with HBOT or PFD decreased IFN-γ expression in the AD lesions. by Hyung-Ran Kim (532404)

IFNγ activates STAT signaling and decreases cell viability of NPCs. by Johanna Mäkelä (223358)

FX06 decreased capillary leak following LPS injection in rats. by Marion Gröger (264663)

Pregnancy is associated with decreased polyubiquitinated protein levels, but not de-ubiqutination levels. by Andrea Iorga (298552)